SCHEMBL20367488

SCHEMBL20367488

CC(=O)N1CCc2cc(C(=O)Nc3cn(Cc4cccc(C(F)(F)F)c4)cn3)ccc2C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.47
TAS2R8 Q9NYW2 1/20 0.46
ABCB1 P08183 1/20 0.45
KCNK3 O14649 1/20 0.44
RORC P51449 1/20 0.42
NAMPT P43490 1/20 0.42
TP53 P04637 1/20 0.41
DDR1 Q08345 2/20 0.41
DDR2 Q16832 2/20 0.41
KCNH2 Q12809 1/20 0.41
NTRK1 P04629 1/20 0.41
NTRK3 Q16288 1/20 0.41
NTRK2 Q16620 1/20 0.41
PTGER4 P35408 2/20 0.40
PTGER2 P43116 1/20 0.40
P2RY14 Q15391 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
PHGDH O43175 1/20 0.40
PRMT5 O14744 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL20162135 0.97 KDM4C (0.46) KDM4CTAS2R8ABCB1KCNK3RORC
SCHEMBL20162109 0.91 TAS2R8 (0.49) KDM4CTAS2R8ABCB1NAMPTDDR1
SCHEMBL20367121 0.90 ABCB1 (0.44) KDM4CTAS2R8ABCB1NAMPT
SCHEMBL20364403 0.88 TAS2R8 (0.53) TAS2R8RORCPRMT5
SCHEMBL20367330 0.87 ABCB1 (0.44) KDM4CTAS2R8ABCB1DDR1DDR2
SCHEMBL20367429 0.85 KDM4C (0.44) KDM4CTAS2R8ABCB1NAMPTKCNH2
SCHEMBL20162181 0.84 KDM4C (0.47) KDM4CTAS2R8ABCB1NAMPTKCNH2
SCHEMBL20367354 0.83 TAS2R8 (0.47) KDM4CTAS2R8KCNH2PTGER4P2RY14
SCHEMBL20162177 0.83 KDM4C (0.46) KDM4CTAS2R8KCNH2P2RY14CYP3A4
SCHEMBL20367225 0.83 KDM4C (0.48) KDM4CTAS2R8NAMPTKCNH2P2RY14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10294237-B2 Bicyclic heterocyclic amide derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2019-05-21 US disclosed
US-20180194773-A1 BICYCLIC HETEROCYCLIC AMIDE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2018-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10294237-B2 Bicyclic heterocyclic amide derivative NR0B1, NR2E1, NR0B2 KDM4C 1041/4885TAS2R8 2479/4885ABCB1 1642/4885
US-20180194773-A1 BICYCLIC HETEROCYCLIC AMIDE DERIVATIVE NR0B1, NR2E1, NR0B2 KDM4C 1041/4885TAS2R8 2479/4885ABCB1 1642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.